These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12547298)

  • 1. P300 changes in major depressive disorders with and without psychotic features.
    Karaaslan F; Gonul AS; Oguz A; Erdinc E; Esel E
    J Affect Disord; 2003 Feb; 73(3):283-7. PubMed ID: 12547298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of atypical antipsychotics in depressive syndromes].
    Quintin P; Thomas P
    Encephale; 2004; 30(6):583-9. PubMed ID: 15738862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Event-related potentials in major depressive disorder: the relationship between P300 and treatment response].
    Işıntaş M; Ak M; Erdem M; Oz O; Ozgen F
    Turk Psikiyatri Derg; 2012; 23(1):33-9. PubMed ID: 22374629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychotic depression--beyond the antidepressant/antipsychotic combination.
    Nelson EB
    Curr Psychiatry Rep; 2012 Dec; 14(6):619-23. PubMed ID: 22936518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of imipramine in psychotic versus nonpsychotic depression.
    Birkenhager TK; van den Broek WW; Mulder PG; Moleman P; Bruijn JA
    J Clin Psychopharmacol; 2008 Apr; 28(2):166-70. PubMed ID: 18344726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affective and psychotic symptoms relate to different types of P300 alteration in depressive disorder.
    Kaustio O; Partanen J; Valkonen-Korhonen M; Viinamäki H; Lehtonen J
    J Affect Disord; 2002 Sep; 71(1-3):43-50. PubMed ID: 12167500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in the treatment of major depressive disorder with psychotic features.
    Rothschild AJ
    Schizophr Bull; 2013 Jul; 39(4):787-96. PubMed ID: 23599251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term response to successful acute pharmacological treatment of psychotic depression.
    Wijkstra J; Burger H; van den Broek WW; Birkenhäger TK; Janzing JG; Boks MP; Bruijn JA; van der Loos ML; Breteler LM; Verkes RJ; Nolen WA
    J Affect Disord; 2010 Jun; 123(1-3):238-42. PubMed ID: 19880189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine-learning-based classification between post-traumatic stress disorder and major depressive disorder using P300 features.
    Shim M; Jin MJ; Im CH; Lee SH
    Neuroimage Clin; 2019; 24():102001. PubMed ID: 31627171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of ziprasidone in combination with sertraline on visually-evoked event-related potentials in depressed patients with psychotic features.
    Moeller O; Evers S; Deckert J; Baune BT; Dannlowski U; Nguyen DH; Arolt V; Hetzel G
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1440-3. PubMed ID: 17669572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychophysiological correlates of patients with delusional misidentification syndromes and psychotic major depression.
    Papageorgiou CC; Alevizos B; Ventouras E; Kontopantelis E; Uzunoglu N; Christodoulou G
    J Affect Disord; 2004 Aug; 81(2):147-52. PubMed ID: 15306140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of depression heterogeneity on attention: an auditory oddball event related potential study.
    Kemp AH; Pe Benito L; Quintana DS; Clark CR; McFarlane A; Mayur P; Harris A; Boyce P; Williams LM
    J Affect Disord; 2010 Jun; 123(1-3):202-7. PubMed ID: 19740547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of unipolar psychotic depression: a randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine.
    Wijkstra J; Burger H; van den Broek WW; Birkenhäger TK; Janzing JG; Boks MP; Bruijn JA; van der Loos ML; Breteler LM; Ramaekers GM; Verkes RJ; Nolen WA
    Acta Psychiatr Scand; 2010 Mar; 121(3):190-200. PubMed ID: 19694628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission and relapse after the first hospital admission in psychotic depression: a 4-year naturalistic follow-up.
    Naz B; Craig TJ; Bromet EJ; Finch SJ; Fochtmann LJ; Carlson GA
    Psychol Med; 2007 Aug; 37(8):1173-81. PubMed ID: 17335639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of antidepressant drugs in schizophrenic patients with depression].
    Micallef J; Fakra E; Blin O
    Encephale; 2006; 32(2 Pt 1):263-9. PubMed ID: 16910628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential response to combined treatment in patients with psychotic versus nonpsychotic major depression.
    Gaudiano BA; Beevers CG; Miller IW
    J Nerv Ment Dis; 2005 Sep; 193(9):625-8. PubMed ID: 16131946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-episode schizophrenic psychosis differs from first-episode affective psychosis and controls in P300 amplitude over left temporal lobe.
    Salisbury DF; Shenton ME; Sherwood AR; Fischer IA; Yurgelun-Todd DA; Tohen M; McCarley RW
    Arch Gen Psychiatry; 1998 Feb; 55(2):173-80. PubMed ID: 9477932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of prior pharmacotherapy on remission of psychotic depression in a randomized controlled trial.
    Blumberger DM; Mulsant BH; Emeremni C; Houck P; Andreescu C; Mazumdar S; Whyte E; Rothschild AJ; Flint AJ; Meyers BS
    J Psychiatr Res; 2011 Jul; 45(7):896-901. PubMed ID: 21300377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Auditory P300 event related potential and serotonin reuptake inhibitor treatment in obsessive-compulsive disorder patients.
    Sanz M; Molina V; Martin-Loeches M; Calcedo A; Rubia FJ
    Psychiatry Res; 2001 Feb; 101(1):75-81. PubMed ID: 11223122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission: The STOP-PD II Randomized Clinical Trial.
    Flint AJ; Meyers BS; Rothschild AJ; Whyte EM; Alexopoulos GS; Rudorfer MV; Marino P; Banerjee S; Pollari CD; Wu Y; Voineskos AN; Mulsant BH;
    JAMA; 2019 Aug; 322(7):622-631. PubMed ID: 31429896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.